banner002.jpg
COVID-19 Update | September 20, 2021
Important Highlights

Updated CDC Guidance for COVID-19 Infection Prevention and Control for HCP 
CDC published updated healthcare personnel infection prevention and control (IP/C) guidance on September 10, which is captured in three main documents: 

 

In an effort to streamline its clinical guidance for healthcare IP/C of COVID-19, CDC is archiving most of the setting-specific guidance and consolidating all healthcare IP/C guidance into the above-listed documents. The new guidance now incorporates considerations for current local community transmission rates and recommendations for immunocompromised people.  

 

Interchangeability of FDA authorized and FDA approved COVID-19 Products   
The FDA-approved Pfizer-BioNTech product COMIRNATY (COVID-19 Vaccine, mRNA) and the FDA-authorized Pfizer-BioNTech COVID-19 Vaccine under EUA have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. Therefore, providers can use doses distributed under the EUA to administer the vaccination series for those seeking the approved vaccine.  The Fact Sheet for Recipients provides additional information about both the approved and authorized vaccine.  Providers should continue to use the vaccines on their shelves. 
 
FDA Issues Revised Policy on Face Masks and Respirators During COVID-19 
The FDA issued a revised guidance: Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) to help expand the availability of face masks, barrier face coverings, and face shields for the general public, including health care personnel, and surgical masks and particulate filtering facepiece respirators (FFRs) (including N95 respirators) for health care personnel for the duration of the COVID-19 public health emergency. 

SHEA Coronavirus News

MySHEA Series – Real-World Approaches to Vaccination as a Condition of Employment in Healthcare 
SHEA is conducting an ongoing MySHEA series to gather real-world examples of how facilities are configuring COVID-19 vaccination as a condition of employment policies. This series is a component of the publicly available tool kit created as a companion resource for the Multisociety Statement. Responses are de-identified and summarized on the Approaches page of the tool kit. So far, topics have included the timing of policy announcements, exemption reviews, and compliance requirements; how vaccine clinics are being set up (in-house, outsourced, etc.); and what mitigation measures are used for those with approved exemptions.  

 

Please note: the tool kit is dynamic, and will evolve with the changing landscape of COVID-19 infection and vaccination science. It will be updated and have additions and subtractions as needed. None of the materials, suggestions, and examples it contains are meant to express the position or endorsement by SHEA, SHEA members, other societies, or the authors. Each individual healthcare facility will need to develop a process appropriate for its context, with advice from counsel on federal, state, local, and other regulations and statutes. If you have questions or suggestions, email vdeloney@shea-online.org.  
 
SHEA Signs on to “Statement of Strong Medical Consensus for Vaccination of Pregnant Individuals against COVID-19"  
SHEA has signed onto a statement led by the American College of Obstetricians and Gynecologists (ACOG), along with APIC, IDSA, SIDP, and many others, that urges all pregnant individuals, including “recently pregnant, individuals planning to become pregnant, lactating, and other eligible individuals to become vaccinated against COVID-19.”  
The SHEA tool kit includes resources to encourage vaccination among groups with lower uptake, and links to this statement and other supporting information to encourage vaccination among pregnant and lactating persons.

Technical Guidance, Standards, and Resources

Vaccines 

FDA Will Follow The Science On COVID-19 Vaccines For Young Children (FDA)

 

CDC COVID-19 Vaccination Program Provider Requirements and Support (CDC)  

 

Vaccines for Children Program vs. CDC COVID-19 Vaccination Program (CDC)  

 

Vaccines and Related Biological Products Advisory Committee September 17, 2021 Meeting Announcement (FDA) 

 

Variants 

*UPDATE* SARS-CoV-2 Variant Classifications and Definitions (CDC) 

 

Monoclonal Antibodies Bamlanivimab and Etesevimab May Be Less Effective for Treating Cases of COVID-19 Caused by Variants (CDC COCA) 

 

MMWRs 

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 (CDC MMWR) 

 
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021 (CDC MMWR) 
 
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021 (CDC MMWR) 
 
Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021 (CDC MMWR) 
 
Using Wastewater Surveillance Data to Support the COVID-19 Response — United States, 2020–2021 (CDC MMWR) 
 
SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 — St. Louis, Missouri, January–May 2021 (CDC MMWR) 
 
Long-Term Care 
 
PPE   
 
Incident Management 
 
Payment and Reimbursement Policy 
 
Research 
Event Announcements

Project Firstline Virtual Town Hall (CDC)  
Fri, Sep 17, 2:15 - 3:00 PM ET  
REGISTER 
CDC experts will discuss the updated IPC guidance and answer questions.

Collaboratives in Action: Equitable Distribution of COVID-19 Vaccines (Institute for Healthcare Improvement) 
Tue, Sep 21, 3 PM – 4 PM 
REGISTER 
Learn how four of these organizations have overcome barriers to equitable vaccine distribution through establishing and leveraging local delivery systems, fostering trust of community members and partnering organizations, and harnessing data. 

Evaluating and Supporting Patients Presenting with Fatigue Following COVID-19 (CDC COCA) 
Thu, Sep 30, 2 PM – 3 PM ET 
REGISTER 
Presenters will discuss Post-COVID conditions (PCC), an umbrella term for the wide range of health consequences present four or more weeks after infection with SARS-CoV-2, which includes Long-COVID. 
SPEAKERS: Maureen Miller, MD, MPH, Joseph E. Herrera, DO, Monica Verduzco Gutierrez, MD, Benjamin Abramoff, MD, MS

Trade Press, Journal Articles, and White Papers

Considerations in Boosting COVID-19 Vaccine Immune Responses. Krause, Philip R, et al.  The Lancet, 2021, doi:10.1016/s0140-6736(21)02046-8.  

Estimates of COVID-19 Cases and Deaths Among Nursing Home Residents Not Reported in Federal Data.Shen K, Loomer L, Abrams H, Grabowski DC, Gandhi A. JAMA Netw Open. 2021;4(9):e2122885. doi:10.1001/jamanetworkopen.2021.22885

Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. Kharbanda EO, Haapala J, DeSilva M, et al. JAMA. Published online September 08, 2021. doi:10.1001/jama.2021.15494 

Equity and the Uneven Distribution of Federal Covid-19 Relief Funds to US Hospitals. Buxbaum, Jason D., and Summer Rak. Health Affairs, vol. 40, no. 9, 2021, pp. 1473–1482., doi:10.1377/hlthaff.2020.02018

News Highlights

Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids | Reuters 

Why the ACLU Flip-Flopped on Vaccine Mandates (The Atlantic)  

facebook-2.png twitterlogowhite.png
banner002.jpg
 

MEMBER ALERT: Updated CDC Guidance for COVID-19 Infection Prevention and Control for HCP

 

Today, CDC posted updated healthcare personnel infection prevention and control (IP/C) guidance that is captured in three main documents:

 

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic

 

Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes

 

Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2

 

In an effort to streamline its clinical guidance for healthcare IP/C of COVID-19, CDC is archiving most of the setting-specific guidance and consolidating all healthcare IP/C guidance into the above-listed documents. The new guidance now incorporates considerations for:

  • current local community transmission rates
  • recommendations for immunocompromised people


In addition to the above critical updates, CDC published a number of other updates summarized in a memo posted in our MySHEA document library including:

  • CDC COVID-19 Vaccination Program Provider Agreements
  • Interchangeability of FDA authorized and FDA approved COVID-19 Products
  • Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
  • Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy
  • Morbidity and Mortality Weekly Report (MMWR) — Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021
  • ICYMI: September 9 COCA Call: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines


We hope you find this information helpful.

facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | September 3, 2021
Important Highlights

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020

Infection Control and Hospital Epidemiology (ICHE) published a paper September 2 authored by the CDC, which discusses the impact of the COVID-19 pandemic on the prevalence of healthcare-associated infections. Read SHEA’s press release along with a commentary authored by two SHEA leaders.
SHEA Coronavirus News

MySHEA Series – Approaches to Vaccination as a Condition of Employment in Healthcare

As part of the tool kit created as a companion resource for the Multisociety Statement, we have initiated a MySHEA series that opens a discussion every few days to get input on the ways members are approaching decisions involved in implementing COVID-19 vaccination as a condition of employment (CoE). We hope this series of forum discussions will help members learn about what other facilities are doing. The order of topics will follow those on the "Approaches" page of the tool kit, which will be updated as topics are covered. The first discussion of the series focused on timing, and the second, posted today, focuses on administration locations. For more information, log into MySHEA.
Technical Guidance, Standards, and Resources

Vaccines

FDA Approves First COVID-19 Vaccine (FDA)

 

Update on CDC COVID-19 vaccine safety monitoring systems: V-safe and VAERS (CDC)

 

Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine (Johnson & Johnson)

 

*UPDATE* Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States (CDC)

 

Strategies for Increasing Adult Vaccination Rates (CDC)

 

The Possibility of COVID-19 after Vaccination: Breakthrough Infections (CDC)

 

COVID-19 Vaccine Breakthrough Case Investigation and Reporting (CDC)

 

Variants

SARS-CoV-2 Variants Circulating in the US (CDC)

 

MMWRs

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 (CDC MMWR)

 

Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men’s Conference — Illinois, June–July 2021 (CDC MMWR)

 

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season (CDC MMWR)

 

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021 (CDC MMWR)

 

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021 (CDC MMWR)

 

COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021 (CDC MMWR)

 

Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021 (CDC MMWR)

 

COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community — Los Angeles County, California, September 2020–March 2021 (CDC MMWR)

 

Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021 (CDC MMWR)

 

Special Settings and Populations

Update: COVID-19 Vaccination During Pregnancy (CDC)

 

COVID-19 Vaccines While Pregnant or Breastfeeding (CDC)

 

CDC launches COVID-19 resources for people with intellectual and developmental disabilities (CDC)

 

Clinical Care

Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19 (CDC)

 

Resumption in Use and Distribution of Bamlanivimab/Etesevimab in all U.S. States, Territories, and Jurisdictions (ASPR)

 

Shelf-Life Extension of Bamlanivimab under the Emergency Use Authorization for Bamlanivimab and Etesevimab Administered Together (ASPR)

 

Stakeholder Calls on COVID-19 Monoclonal Antibody Therapeutics (ASPR)

 

Occupational Health

List of Agencies and Organizations with COVID-19 Vaccination Condition of Employment Policies (SHEA)

 

PPE  

Respiratory Protection Week 2021 (CDC)

 

Communication Resources

COVID-19 Monoclonal Antibody Therapeutics Communications Toolkit (ASPR)

 

Resource: FDA Approval Messaging and Outreach Tools (Public Health Communications Collaborative)

 

Misinformation Alerts (Public Health Communications Collaborative)

 

Payment and Reimbursement Policy

CMS Issued Guidance on COVID-19 Testing and Vaccine Expenditures (WHG)

 

Research and Resources Development Funding Opportunities
Information for Patients, Visitors, and the General Public 

*UPDATE* V-safe After Vaccination Health Checker (CDC)

 

*VIDEO* Families: Use v-safe after COVID-19 vaccination (CDC)

 

*NEW* COVID-19 Materials for People with Intellectual and Developmental Disabilities and Care Providers (CDC)

 

*NEW* A Guide for Caregivers (CDC)

Event Announcements

Authorities Associated with Respiratory Protection - The Role of NIOSH, the FDA, and OSHA

Sep 9, 3 PM ET

REGISTER

A webinar to clarify information regarding the U.S. Respiratory Protection authorities. a deeper dive into this subject and define each agency’s role. Speakers from NIOSH, the Food and Drug Administration (FDA) and the Occupational Safety and Health Administration (OSHA) will come together during NIOSH’s Respiratory Protection Week to provide an overview and discussion about the roles of these agencies during both conventional operations and emergency response scenarios.

 

2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

Sep 9, 2 PM – 3 PM ET

REGISTER

During this COCA Call, presenters will provide updates on the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2021-2022 influenza vaccination season and guidance for coadministration of influenza and COVID-19 vaccines.

Speakers: CAPT Lisa Grohskopf, MD, MPH, Andrew Kroger, MD, MPH

facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | August 20, 2021
Important Highlights

Biden-Harris Administration Announces HCP Vaccine Requirement for Nursing Homes

Yesterday, the Biden Administration announced that it would be requiring COVID-19 vaccinations for all HCP in Medicare-Medicaid participating nursing homes through an emergency rulemaking.

 

Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

The U.S. Department of Health and Human Services (HHS) announced on August 18 the Administration’s plan for COVID-19 boosters. The announcement was accompanied by the release of three studies published in the Morbidity and Mortality Weekly Report:

 

CDC Stands Up New Disease Forecasting Center

The CDC announced a new center designed to advance the use of forecasting and outbreak analytics in public health decision making. The center was developed through funding from the American Rescue Plan and will focus on three key functions:

  • Predict: Undertake modeling and forecasting; enhance the ability to determine the foundational data sources needed; support research and innovation in outbreak analytics and science for real-time action; and establish appropriate forecasting horizons.
  • Connect: Expand broad capability for data sharing and integration; maximize interoperability with data standards and utilize open-source software and application programming interface capabilities, with existing and new data streams from the public health ecosystem and beyond.
  • Inform: Translate and communicate forecasts; connect with key decision-makers across sectors including government, businesses, and non-profits, along with individuals with strong intergovernmental affairs and communication capacity for action.
SHEA Coronavirus News
SHEA Comments: OSHA COVID-19 Emergency Temporary Standard Interim Final Rule
SHEA submitted comments to OSHA in response to the agency's COVID-19 emergency temporary standard interim final rule. The comment period closes August 20. The letter was developed collaboratively by the SHEA Public Policy and Government Affairs Committee and the Guidelines Committee.
 
Implementation Tool Kit Available for COVID-19 Vaccination as a Condition of Employment in Healthcare
The tool kit to assist facilities in developing and implementing policies for COVID-19 vaccination as a requirement for healthcare personnel is now available for SHEA members. It will be publicly available starting the week of Aug. 23. The tool kit will continue to be updated over the coming weeks. Check back regularly for updates.

 
Technical Guidance, Standards, and Resources

Vaccines

Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine (BusinessWire)

 

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States (CDC)

 

Selected Adverse Events Reported after COVID-19 Vaccination (CDC)

 

COVID-19 Vaccines for People Who Would Like to Have a Baby (CDC)

 

COVID-19 Vaccine Monitoring Systems for Pregnant People (CDC)

 

Boosters

 

COVID-19 Vaccines for Moderately to Severely Immunocompromised People (CDC)

 

FACT SHEET: President Biden to Announce New Actions to Protect Americans from COVID-⁠19 and Help State and Local Leaders Fight the Virus (The White House)

 

MMWRs

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 (CDC MMWR)

 

Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (CDC MMWR)

 

Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — Mesa County, Colorado, April–June 2021 (CDC MMWR)

 

Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 (CDC MMWR)

 

Diversity and Equity

Health Equity and Disparities During the COVID-19 Pandemic: Brief Overview of the Federal Role (Congressional Research Service)

 

Testing and Cases

Testing Strategies for SARS-CoV-2 (CDC)

 

Occupational Health

 OSHA Updates COVID-19 Safety Guidance for All Industries (OSHA)

 

Incident Management

Learning from 2020: Preparing for a Second COVID-19 Hurricane Season (CDC)

 

Going to a Public Disaster Shelter During the COVID-19 Pandemic (CDC)

 

Payment and Reimbursement Policy

CMS Provider Resources for COVID-19 Vaccine Administration

 

Information for Patients, Visitors, and the General Public 

Resource: Messaging for Vaccine Boosters (Public Health Communications Collaborative)

 

Resource: AANHPI COVID-19 Community Corps In-Language Resource Guide (Asian & Pacific Islander American Health Forum)

 

Guidance for COVID-19 Prevention in K-12 Schools (CDC)

Event Announcements

CDC COVID-19 Partner Update: Mental Health is Public Health: Tools for State and Local Partners During COVID-19 (CDC)

Aug 23, 4:00 PM ET

REGISTER

Dr. Elissa Meites will share updates on CDC’s COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others. Dr. Debra Houry will speak about CDC's work around mental health and Ms. Ahoua Kone will provide information on mental health tools and resources for state and local public health partners.

 

COVID-19 Vaccine Confidence in Geographic Areas of Need (Alliance for Health Policy)

Aug 25, 12:00 pm – 1:15 pm ET

REGISTER

This briefing will discuss survey findings that reveal discrimination, location, and messaging continue to be factors that influence whether ethnic and racial minority communities will choose to receive the COVID-19 vaccine. Following discussion of the results, the panel will explore potential strategies to increase vaccination rates, particularly ones tailored to different populations.

Trade Press, Journal Articles, and White Papers

Suspected SARS-CoV-2 reinfections: Incidence, predictors, and healthcare use among patients at 238 U.S. healthcare facilities, June 1, 2020- February 28, 2021.

Lawandi A, Warner S, Sun J, Demirkale CY, Danner RL, Klompas M, Gundlapalli A, Datta D, Harris AM, Morris SB, Natarajan P, Kadri SS. Clin Infect Dis. 2021 Aug 5.

 

Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.

Yoon P, Hall J, Fuld J, et al. MMWR Morb Mortal Wkly Rep 2021;70:1075–1080.

 

Receipt of Mrna COVID-19 Vaccines Preconception and during Pregnancy and Risk of Self-Reported Spontaneous Abortions, CDC V-SAFE Covid-19 Vaccine Pregnancy REGISTRY 2020-21. Zauche, Lauren Head, et al. 2021, doi:10.21203/rs.3.rs-798175/v1.

 

Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020 (Health Affairs)

 

Evidence Of Respiratory Infection Transmission Within Physician Offices Could Inform Outpatient Infection Control (Health Affairs)

 

Innovation At The Centers For Medicare And Medicaid Services: A Vision For The Next 10 Years (Health Affairs Blog)

 

Pandemic-driven push for U.S.-made PPE may fade (Modern Healthcare)

facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | August 6, 2021
Technical Guidance, Standards and Resources
Vaccines 
 
 
Infection Prevention and Control 
 
 
Special Settings and Populations 
 
Occupational Health 
Information for Patients, Visitors, and the General Public
Tough Q&A on the new masking guidance (Public Health Communications Collaborative)
 
Trade Press, Journal Articles, and White Papers
 
Risk Factors and Outcomes Associated with Community-Onset and Hospital-Acquired Co-infection in Patients Hospitalized for COVID-19: A Multi-Hospital Cohort StudyLindsay A. Petty, Scott A. Flanders, Valerie M. Vaughn, David Ratz, Megan O’Malley, Anurag N. Malani, Laraine Washer, Tae Kim, Keith E. Kocher, Scott Kaatz, Tawny Czilok, Elizabeth McLaughlin, Hallie C. Prescott, Vineet Chopra, and Tejal GandhiInfection Control & Hospital Epidemiology, 1-28. doi:10.1017/ice.2021.341
News Highlights
Federal Policy Updates
COVID-19: Continued Attention Needed to Enhance Federal Preparedness, Response, Service Delivery, and Program Integrity (GAO) 
facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | July 23, 2021
SHEA Coronavirus News
Technical Guidance, Standards and Resources
Variants 
Vaccines 
 
MMWRs 
COVID-19 Vaccine Administration, by Race and Ethnicity — North Carolina, December 14, 2020–April 6, 2021 (CDC MMRW)   
 
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021 (CDC MMRW)  
 
SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility — Oklahoma, April–May 2021 (CDC MMRW)   
 
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 (CDC MMWR)  
 
Outcomes Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 diagnosis — United States, January 2020–March 2021 (CDC MMWR)  
 
Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents — United States, April 15–23, 2021 (CDC MMWR)  
 
Special Settings and Populations  
 
Clinical Care  
 
Testing and Cases 
 
PPE   
 
Quality Reporting 
 
Communication Resources 
 
Payment and Reimbursement Policy 
 
Research 
Information for Patients, Visitors, and the General Public
When You Can be Around Others After You Had or Likely Had COVID-19 (CDC)  
 
Families with Vaccinated and Unvaccinated Members (CDC)  
 
*UPDATE* When You’ve Been Fully Vaccinated (CDC)  
Trade Press, Journal Articles, and White Papers
Multisociety Statement on COVID-19 Vaccination as a Condition of Employment for Healthcare Personnel. Weber, D., Al-Tawfiq, J., Babcock, H., Bryant, K., Drees, M., Elshaboury, R., . . . Young, H. (2021). Infection Control & Hospital Epidemiology, 1-46. doi:10.1017/ice.2021.322 (ICHE)  
 
Healthcare Facilities Should Publicly Report the COVID-19 Vaccination Coverage of Healthcare Personnel. Yang, J., Babcock, H., & Baghdadi, J. (2021).  Infection Control & Hospital Epidemiology, 1-6. doi:10.1017/ice.2021.319 (ICHE)  
 
Estimated Mortality Increases During The COVID-19 Pandemic By Socioeconomic Status, Race, And Ethnicity (Health Affairs)  
 
COVID-19-Related Deaths and Excess Deaths Among Medicare Fee-For-Service Beneficiaries (Health Affairs)  
 
Larger Nursing Home Staff Size Linked to Higher Number Of COVID-19 Cases In 2020 (Health Affairs) 
News Highlights
American Hospital Association supports COVID-19 vaccine mandates (Modern Healthcare)  
 
America’s Essential Hospitals Urges Members to Require Employee Vaccination (America’s Essential Hospitals)  
 
Another medical professional group pushes for mandated vaccines (Modern Healthcare)  
 
Unvaccinated staff eyed in rising nursing home cases, deaths (AP)   
 
Delta COVID-19 variant now 83% of US cases (CIDRAP)  
 
How Delta is pushing the U.S. into a new phase of the Covid-19 pandemic (STAT)  
 
Osterholm Update Podcast: COVID-19 Episode 61: Divided by Delta (CIDRAP)  
 
Gist Healthcare Daily Podcast - Calls for vaccine mandates for healthcare workers intensify (Gist Healthcare Daily)  
 
U.S. at 'another pivotal moment,’ says CDC's Walensky (Reuters)  
Federal Policy Updates
COVID-19: Continued Attention Needed to Enhance Federal Preparedness, Response, Service Delivery, and Program Integrity (GAO)  
 
Hearing: The Path Forward: A Federal Perspective on the COVID-19 Response (Senate HELP) 

 
facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | July 9, 2021
SHEA Coronavirus News
SHEA Converse & Convene: Restrictions After Vaccinations Revisited 
July 23, 2021 | 11:00 am-12:00 pm EST   
REGISTER HERE    
This members-only networking event will again focus on restrictions after receiving COVID-19 vaccinations. Please note this event is not recorded and is intended for members to have an open, candid discussion around this topic.   
  
Moderator: Hana Hakim, MD; St Jude Children’s Research Hospital
Technical Guidance, Standards and Resources
Variants 

MMWRs 
Event Announcements
CDC COVID-19 Partner Update: COVID-19 and Returning to School
Jul 19, 3 - 4 PM
REGISTER
Trade Press, Journal Articles, and White Papers
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines
Shay DK, Shimabukuro TT, DeStefano F. JAMA Cardiol. Published online June 29, 2021. doi:10.1001/jamacardio.2021.2821
SHEA Education and Events
New this week:
  1. Podcast: Getting COVID Under Control and Keeping it that Way
  2. Town Hall Round 51
    Sunday, July 11, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | July 2, 2021
Important Highlights
At the direction of the SHEA Board, a multidisciplinary panel made up of Board Members, Guidelines Committee Members, and other SHEA leaders, as well as representatives from AMDA, APIC, HIVMA, IDSA, PIDS, and SIDP, and a group of legal and HR experts has produced a consensus document on COVID-19 vaccination as a condition of employment for healthcare personnel. It is under review by these organizations' leadership at this time. Please stay tuned for more information; we will notify you of release through a variety of channels upon finalization. 
Technical Guidance, Standards and Resources
Vaccines 
 
MMWRs 
Disparities in Learning Mode Access Among K–12 Students During the COVID-19 Pandemic, by Race/Ethnicity, Geography, and Grade Level — United States, September 2020–April 2021 (CDC MMWR)  
 
COVID-19 Vaccination Coverage Among Adults — United States, December 14, 2020–May 22, 2021 (CDC MMWR) 
  
COVID-19 Vaccination Coverage and Intent Among Adults Aged 18–39 Years — United States, March–May 2021 (CDC MMWR)  
 
Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021 (CDC MMWR)  
 
COVID-19 Surveillance and Investigations in Workplaces — Seattle & King County, Washington, June 15–November 15, 2020 (CDC MMWR)  
 
Infection Prevention and Control 
 
Long-Term Care 
 
Testing and Cases 
SHEA Education and Events
New this week:
  1. Podcast: International Perspectives from India
  2. Town Hall Round 51
    Sunday, July 11, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
banner002.jpg
COVID-19 Update | June 18, 2021
Important Highlights
Interim Guidance: Evaluating and Caring for Patients with Post-COVID Conditions (CDC)
The Centers for Disease Control and Prevention’s (CDC) interim guidance on post-COVID conditions provides new information to assist healthcare professionals with evaluating, managing, and caring for patients who may experience long-term effects after a COVID-19 infection. Information in this guidance is based on medical expert opinion, feedback from U.S. medical associations and patient advocacy groups, and available data.
 
Key Points   
  • The term “Post-COVID Conditions” is an umbrella term for the wide range of physical and mental health consequences experienced by some patients that are present four or more weeks after SARS-CoV-2 infection, including by patients who had initial mild or asymptomatic acute infection.  
  • CDC does not recommend requiring a previous positive test for COVID-19 to consider whether a patient has a post-COVID condition. Testing capacity was limited early in the pandemic and access to care even today is not equitable for all individuals, resulting in some persons being unable to be tested. Additionally, some people may have been infected but asymptomatic or only with mild symptoms and thus did not seek out testing.  
  • Based on current information, many post-COVID conditions can be managed by primary care providers, with the incorporation of patient-centered approaches to optimize the quality of life and function in affected patients.  
  • Objective laboratory or imaging findings should not be used as the only measure or assessment of a patient’s wellbeing; lack of laboratory or imaging abnormalities does not invalidate the existence, severity, or importance of a patient’s symptoms or conditions.   
  • Healthcare professionals and patients are encouraged to set achievable goals through shared decision-making and to approach treatment by focusing on specific symptoms (e.g., headache) or conditions (e.g., dysautonomia); a comprehensive management plan focusing on improving physical, mental, and social wellbeing may be helpful for some patients.   
  • Understanding of post-COVID conditions remains incomplete and guidance for healthcare professionals will likely change over time as the evidence evolves.  
COCA Webinar: Evaluating and Caring for Patients with Post-COVID Conditions (CDC)
Recording of the webinar held June 17 about the CDC’s new interim guidance which provides a framework for healthcare providers in their initial assessment, evaluation, management, and follow-up of persons with possible post-COVID conditions.
Technical Guidance, Standards and Resources
Vaccines 
Vaccines and Related Biological Products Advisory Committee – 6/10/2021 (FDA)
MMWRs
 
Clinical Care 
 
Testing and Cases
 
Event Announcements
CDC COVID-19 Partner Update: A Call to Action: Mobilizing America to Vaccinate Against COVID-19 (CDC)
Mon. Jun 21, 3:00 pm
Description: Updates on guidance around post-COVID conditions; information on the National Month of Action to mobilize an all-of-America sprint to get of as many U.S. adults as possible at least one shot by July 4th.
Speakers: Dr. Jennifer Chevinsky, Dr. Jennifer Layden, Dr. Allison Taylor Walker, Mr. Angel Roca
 
COVID-19 Vaccination and Children: Answering Parents’ Questions (Public Health Communications Collaborative)
Wed., Jun 23, 1 pm
Description: Webinar focused on COVID-19 communications to answer parents’ questions about COVID-19 vaccination for children.
Speakers: Karen Remley, MD, MBA, MPH, FAAP, Nicole Alexander-Scott, MD, MPH, Lisa Waddell, MD, MPH
News Highlights
Federal Policy Updates
SHEA Education and Events
New this week:
facebook-2.png twitterlogowhite.png
 
banner002.jpg
COVID-19 Update | June 11, 2021
Important Highlights
New OSHA Emergency Temporary Standard for Healthcare Settings 
The Occupational Safety and Health Administration (OSHA) issued an emergency temporary standard (ETS) on June 10 aimed at protecting workers in healthcare settings from COVID-19. OSHA also updated its COVID-19 guidance for employers and workers not covered by the new ETS. A detailed analysis can be found below in the Federal Policy Updates section. 
 
SLIDES: CDC Vaccines and Related Biological Products Advisory Committee (VRPBAC) June 10 meeting on vaccine safety. As of May 31, VAERS has received 475 reports of myocarditis or pericarditis among people 30 years of age and younger who received a COVID-19 vaccine. CDC and FDA have confirmed 226 reports meet CDC’s working case definition. Reports are rare, given the >18 million doses administered to people between ages 12-24 in the US. CDC continues to recommend COVID-19 vaccination for everyone 12 years and older.
SHEA Coronavirus News
SHEA Converse & Convene: Maintaining Focus on Other Healthcare Epidemiology Issues During COVID
(Open to SHEA Members)   
REGISTER HERE   
This members-only networking event will focus on questions related to working on other healthcare epi issues while focusing on COVID-19. Please note this event is not recorded and is intended for members to have an open, candid discussion around this topic.   
 
Moderator: Theresa Madaline, MD; NYC Health and Hospitals
Technical Guidance, Standards and Resources
Vaccines 
 
MMWRs 
Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine — United States, September 6, 2020–May 1, 2021 (CDC MMWR)  
 
Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine — United States, September 6, 2020–May 1, 2021 (CDC MMWR)  
 
Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021 (CDC MMWR)  
 
Impact of Policy and Funding Decisions on COVID-19 Surveillance Operations and Case Reports — South Sudan, April 2020–February 2021 (CDC MMWR) 
 
COVID-19 Severity and COVID-19–Associated Deaths Among Hospitalized Patients with HIV Infection — Zambia, March–December 2020 (CDC MMWR)  
 
Infection Prevention and Control 
 
Long-Term Care 
COVID-19 in Nursing Homes: Most Homes Had Multiple Outbreaks and Weeks of Sustained Transmission from May 2020 through January 2021 (GAO) 
Clinical Care  
 
Incident Management 
 
Payment and Reimbursement Policy 
Research and Resources Development Funding Opportunities
Trade Press, Journal Articles, and White Papers
Underlying Medical Conditions Associated with Severe COVID-19 Illness Among Children  
Kompaniyets L, Agathis NT, Nelson JM, et al. JAMA Netw Open. 2021;4(6):e2111182. doi:10.1001/jamanetworkopen.2021.11182  
  
Differences between children with severe acute lower respiratory infection with or without SARS-CoV-2 infection 
Vivian Botelho Lorenzo, Cristiana Nascimento-Carvalho. Journal of Infection. Published: June 03,2021  
 
COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs  
Talbot TR. JAMA. Published online June 07, 2021. doi:10.1001/jama.2021.8901
Federal Policy Updates
New OSHA Emergency Temporary Standard for Healthcare Settings 
The Occupational Safety and Health Administration (OSHA) issued an emergency temporary standard (ETS) aimed at protecting workers in healthcare settings from COVID-19. OSHA also updated its COVID-19 guidance for employers and workers not covered by the new ETS. The ETS is an interim final rule that will take effect immediately upon publication in the Federal Register. Employers must comply with most requirements within 14 days, and with other requirements relating to physical barriers, ventilation, and training within 30 days.  
 
The ETS applies only to employees in healthcare settings – specifically, hospitals, nursing homes, and assisted living facilities; emergency responders; home healthcare workers and employees in ambulatory care facilities where suspected or confirmed COVID-19 patients are treated.  There are some exceptions, outlined on pp. 1-3 of the public inspection copy (Subpart U). Exceptions include “well-defined hospital ambulatory care settings where all employees are fully vaccinated and all non-employees are screened prior to entry and people with suspected or confirmed COVID-19 are not permitted to enter those settings”; “home healthcare settings where all employees are fully vaccinated and all non-employees are screened prior to entry and people with suspected or confirmed COVID-19 are not present”; among other settings. See flow chart to determine whether your workplace is covered by ETS.  
 
Employer Requirements – Beginning on p. 9, the ETS delineates key requirements. They include developing and implementing a COVID-19 plan that includes a designated safety coordinator, a workplace-specific hazard assessment, and policies and procedures to minimize the risk of transmission of COVID-19. See fact sheet for overview of all requirements. Additional requirements relate to: 
  • Patient screening and management (p.11) 
  • Standard and transmission-based precautions (p. 12)  
  • Personal protective equipment (PPE) (p. 13) 
  • Aerosol-generating procedures on a person with suspected or confirmed COVID-19 (p. 17) 
  • Physical distancing (p. 17) 
  • Physical barriers (p. 18) 
  • Cleaning and disinfection (p. 18) 
  • Ventilation (p. 18) 
  • Health screening and medical management (p. 20); 
  • Vaccination (p. 28): The ETS does not require employers to mandate COVID-19 vaccination, but it does require employers to provide employees with “reasonable time and paid leave” for vaccination and recovery from any side effects.  
  • Training (p. 28) 
  • Anti-retaliation (p. 30)
Beginning on p. 34, the ETS provides requirements for the mini respiratory protection program, which applies to circumstances when “when workers are not exposed to suspected or confirmed sources of COVID-19 but where respirator use could offer enhanced worker protection.” See fact sheet for details. The ETS requires employers with more than 10 employees to retain records, including a COVID-19 log to record COVID-19 cases in their workforce. See fact sheet for log requirements. It requires employers to report all work-related COVID-19 fatalities and in-patient hospitalizations to OSHA. See fact sheet for details. 
 
Comments are due 30 days after publication in the Federal Register. 
SHEA Education and Events
New this week:
  1. Podcast: COVID-19 in Children & the Pediatric Vaccine
  2. Town Hall Round 50:
    Sunday, June 27, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | June 6, 2021
Important Highlights
CDC Questions and Answers Regarding COVID-19 IPC in Healthcare Settings
Representatives from the CDC provided responses to a short list of questions forwarded by SHEA leaders and other collaborating organizations:
 
Question 1: Are there plans to change mask recommendations (source control) for healthcare personnel when in non-patient facing areas?
Answer 1: CDC continues to modify recommendations for healthcare settings as conditions in the United States evolve and as we gain a broader understanding of the effect of vaccination. Currently CDC recommends healthcare personnel use source control while in a healthcare facility when not using personnel protective equipment. The current post-vaccination healthcare guidance does allow for removal of source control when in separate, non-patient areas and among other vaccinated staff (conference rooms, break rooms). We are discussing expansion of these recommendations as community prevalence continues to fall and as other settings modify their guidance. This is still an area of active discussion and no definitive plans for next steps have been made.
 
Question 2: Are there plans to change current screening recommendations for healthcare facilities? This process currently has a low yield. 
Answer 2: Currently screening is recommended for healthcare settings but alternatives to in-person screening are provided. CDC has proposed updates to the main infection control guidance that are expected to be forthcoming in the near future.
 
Question 3: Is CDC considering removing the recommendation for gowns and gloves (contact precautions) for patients known or suspected to be infected with SARS-CoV-2?
Answer 3: In light of the lack of evidence on the role contact transmission plays in the spread of SARS-CoV-2 in healthcare settings, CDC is not currently prepared to remove the recommendation for the use of gowns and gloves by healthcare personnel caring for patients with known or suspected SARS-CoV-2 infection. CDC is considering what additional data might be required to inform this decision and considering further input on this issue from other outside experts.
SHEA Coronavirus News
Grab your favorite morning beverage, turn on your camera and come have an open, candid hour-long conversation about how COVID-19 is impacting you, your work, and anything and everything in between. This Converse and Convene: COVID-19 will focus on questions related to Maintaining Focus on Other Healthcare Epi Issues During COVID-19. Please note this event is not recorded and is intended for members to have an open, candid discussion around the selected topic. This event is open to SHEA members only at this time.
 
Moderator: 
Theresa Madaline, MD
NYC Health and Hospitals
Technical Guidance, Standards and Resources
MMWRs 
SHEA Education and Events
New this week:
  1. Town Hall Round 49:
    Sunday, June 6, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic
banner002.jpg
COVID-19 Update | May 28, 2021
Important Highlights
Your input is needed on COVID-19 hospital data reporting
The Centers for Disease Control and Prevention (CDC) in partnership with the HHS Office of the Assistant Secretary for Preparedness (ASPR) and other federal agency partners, collectively organized as the Data Strategy and Execution Working (DSEW) Group, is seeking consultation from SHEA as part of a process to inform a comprehensive re-evaluation and refinement of the COVID-19 data elements that hospitals are currently required to report.  DSEW is seeking feedback on your current experience with the hospital reporting requirements and recommended changes that could reduce reporting burden, improve data quality, and ensure critical data are available to guide public health action. Representatives from the DSEW have compiled a set of questions to help guide you in providing your feedback. Please assist SHEA and our federal partners by logging into LearningCE and completing a set of questions. Completing this survey may take 10-30 minutes depending on how much detail you choose to provide and the number of colleagues you may need to consult within your institution. The survey will remain open until Thursday, June 3, close of business. If you experience difficulties accessing the survey, please email info@shea-online.org.
Technical Guidance, Standards and Resources
Variants 
 
Vaccines 
 
MMWRs 
 
Special Settings and Populations 

Incident Management
SHEA Education and Events
New this week:
  1. Podcast: How COVID is Exposing Racial & Ethnic Healthcare Disparities
     
  2. Town Hall Round 49:
    Sunday, June 6, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic
banner002.jpg
COVID-19 Update | May 21, 2021
Important Highlights
EMA assessing reports of myocarditis with Comirnaty and COVID-19 Vaccine Moderna
In recent weeks, there have been reports of myocarditis occurring after COVID-19 vaccination, including in Europe, where the European Medicines Agency (EMA) recently requested data from Pfizer and Moderna on reports of myocarditis and pericarditis after vaccination. CDC is aware of these reports, which are rare given the number of vaccine doses administered and continues to monitor available data.  
  
Myocarditis is the inflammation of the heart muscle and pericarditis is the inflammation of the lining outside the heart. In both cases, the body's immune system is causing inflammation in response to an infection or some other trigger. While myocarditis can be serious, it is frequently mild and self-limited. Symptoms can include abnormal heart rhythms, shortness of breath, or chest pain. 
  
As part of COVID-19 vaccine safety efforts, CDC has been closely monitoring myocarditis/pericarditis in multiple safety systems, including the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD).  
  
To date, there has not been a safety signal identified in either VAERS or VSD. CDC will continue to evaluate reports of myocarditis/pericarditis occurring after COVID-19 vaccination and will share more information as it becomes available. Healthcare providers should consider myocarditis in an evaluation of chest pain after vaccination and report all cases to VAERS.  
  
CDC continues to recommend COVID-19 vaccination for people 12 years and older.
Technical Guidance, Standards and Resources
 
MMWRs 
 
Event Announcements
CDC COVID-19 Partner Update: Pregnant during a Pandemic: What the data say about COVID-19 and the Vaccine 
Mon. May 24, 3 PM ET
REGISTER
Drs. Romeo Galang and Kara Polen will share information on vaccine safety and efficacy for pregnant individuals, as well as the latest scientific information and what everyone should know about protecting themselves and others. Then Dr. Galang and Ms. Polen will be answering your questions pre-submitted by email
SHEA Education and Events
New this week:
  1. Podcasts:
    Impact of COVID-19 on Women in Healthcare
    Post-Acute Sequelae of COVID-19

     
  2. Town Hall Round 48:
    Sunday, May 23, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | May 14, 2021
Important Highlights
SHEA STATEMENT: Healthcare Personnel Must Continue SARS-CoV-2 Prevention, Even as Community Guidelines Relax
 
SHEA issued a statement warning that it is imperative to continue vigilant infection prevention practices against SARS-CoV-2 in healthcare facilities even as community prevention measures for vaccinated people begin to relax.
 
The Centers for Disease Control and Prevention (CDC) announced today that people fully vaccinated against SARS-CoV-2 do not need to wear masks or practice physical distancing indoors or outdoors, except under certain circumstances.
 
SHEA is excited that epidemiological data has confirmed vaccine effectiveness in community settings in recent months. We agree with the recommendations relaxing requirements for post-exposure, and post-travel, quarantine and testing for fully vaccinated individuals.  However, SHEA strongly cautions against relaxing transmission mitigation efforts including masking in communities with ongoing high rates of transmission and within healthcare settings. We endorse and re-emphasize the CDC’s continued recommendation for universal masking in all healthcare settings.
 
CDC recommends that healthcare personnel continue to follow all current infection prevention and control recommendations for SARS-CoV-2, to protect themselves and others from infection.
 
For healthcare personnel, it is often not known whether patients have been vaccinated when they first arrive in need of care, and we provide care for many highly immunocompromised patients who may remain vulnerable to COVID-19 even after vaccination. The potential for exposure to SARS-CoV-2 is not limited to direct patient care interactions since transmission can also occur through unprotected exposures to asymptomatic or pre-symptomatic co-workers or visitors in common areas, whose vaccination status may also not be known.
 
SHEA maintains that for the safety of all healthcare personnel and patients, appropriate personal protective equipment (PPE) use is critical. All healthcare personnel should continue to adhere to policies and procedures specific for healthcare settings.
 
SHEA’s vision statement is “Safe Healthcare for All.” To accomplish this, SHEA supports continued adherence to SARS-CoV-2 transmission mitigation recommendations to prevent the spread of infections and to ensure that the United States sustains the growing progress in our fight to end the pandemic.
 
SHEA Coronavirus News
SHEA Converse & Convene: Restrictions After COVID-19 (Open to SHEA Members) 
Friday, May 21, 2021 | 11:00 a.m. - 12:00 p.m. ET
REGISTER HERE 
This members-only networking event will focus on questions related to restrictions as we start coming out of the pandemic. Please note this event is not recorded and is intended for members to have a candid discussion around this topic. 
Moderator: Hana Hakim, MD, St. Jude Children’s Research Hospital 
Technical Guidance, Standards and Resources
COVID-19 Vaccines for Children and Teens  
CDC recommends COVID-19 vaccination for everyone 12 years of age and older to help protect against COVID-19. Children 12 years of age and older are able to get the Pfizer-BioNTech COVID-19 Vaccine.
 
Pediatric Healthcare Professionals COVID-19 Vaccination Toolkit  
The materials on this page will help you share clear and accurate information about COVID-19 vaccines when starting or continuing conversations with parents/guardians, as well as information for those who choose not to vaccinate their child.
 
Parent fact sheet: COVID-19 Vaccines for Children and Teens 
Interim Public Health Recommendations for Fully Vaccinated People
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html 
  • Update that fully vaccinated people no longer need to wear a mask or physically distance in any setting, except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance
  • Update that fully vaccinated people can refrain from testing following a known exposure unless they are residents or employees of a correctional or detention facility or a homeless shelter
 
SHEA Education and Events
New this week:
  1. Podcast: Post-Acute Sequelae of COVID-19
  2. Town Hall Round 47:
    Sunday, May 16, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | May 7, 2021
SHEA Coronavirus News
SHEA Converse & Convene: Restrictions After COVID-19 (Open to SHEA Members) 
Friday, May 21, 2021 | 11:00 a.m. - 12:00 p.m. ET
REGISTER HERE 
This members-only networking event will focus on questions related to restrictions as we start coming out of the pandemic. Please note this event is not recorded and is intended for members to have a candid discussion around this topic. 
Moderator: Hana Hakim, MD, St. Jude Children’s Research Hospital 
Technical Guidance, Standards and Resources
Variants 
 
Janssen (Johnson & Johnson) 
 
Vaccines 
 
MMWRs 
 
Long-Term Care 
 
Special Settings and Populations 
 
Occupational Health 
 
Communication Resources 
 
Payment and Reimbursement Policy 
Research and Resources Development Funding Opportunities
News Highlights
The F.D.A. is set to authorize the Pfizer-BioNTech vaccine for those 12-15 years old by early next week (NY Times)  
 
Pfizer plans to request COVID-19 vaccine EUA for ages 2-11 in September (AAP News)  
 
White House will make unordered vaccine supply available to other states (Washington Post)  
 
The coronavirus vaccine skeptics who changed their minds (Washington Post)  
 
Biden aims to vaccinate 70% of American adults by July 4 (AP) 
SHEA Education and Events
New this week:
  1. Podcast: Impact of COVID-19 on Women in Healthcare
  2. Town Hall Round 47:
    Sunday, May 16, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | April 30, 2021
SHEA Coronavirus News
SHEA Converse & Convene: Restrictions After COVID-19 (Open to SHEA Members) 
REGISTER HERE 
This members-only networking event will focus on questions related to restrictions as we start coming out of the pandemic. Please note this event is not recorded and is intended for members to have a candid discussion around this topic. 
Moderator: Hana Hakim, MD, St. Jude Children’s Research Hospital 
Technical Guidance, Standards and Resources
Variants 
Vaccines 
MMWRs 
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 (CDC MMWR)  
 
COVID-19 Outbreak Among Farmworkers — Okanogan County, Washington, May–August 2020 (CDC MMWR)  
 
Linked Clusters of SARS-CoV-2 Variant B.1.351 — Maryland, January–February 2021 (CDC MMWR)  
 
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 (CDC MMWR)  
 
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021 (CDC MMWR)  
 
Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28–180 Days After COVID-19 Diagnosis — Georgia, May 2020–March 2021 (CDC MMWR)  
 
Infection Prevention and Control 
 
Long-Term Care 
 
Special Settings and Populations 
 
PPE   
 
Communication Resources 
 
Research 
Information for Patients, Visitiors, and the General Public
When You’ve Been Fully Vaccinated (CDC)  
SHEA Education and Events
New this week:
  1. Podcast: SHEA Spring Recap
  2. Town Hall:
    Round 47 | Sunday, May 16, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | April 23, 2021
Technical Guidance, Standards and Resources
Variants
 
J&J Vaccines
 
Vaccines
 
MMWRs
 
Infection Prevention and Control
 
Long-Term Care
 
Special Settings and Populations
 
Clinical Care
 
Occupational Health
 
PPE 
 
Research
Information for Patients, Visitiors, and the General Public
 
 
Answers to Tough Questions about Public Health (Public Health Communications Collaborative)
 
Event Announcements
CDC COVID-19 Partner Update: Keeping up With Critical Diabetes Care and Prevention During COVID-19 (CDC)
Mon., Apr. 26, 3 PM
REGISTER HERE
Dr. Kyle Bernstein will share updates on CDC’s COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others. Dr. Beth Bigman will discuss how to maintain critical diabetes care and prevention during the pandemic.
 
COVID-19 Communications: Real-World Insights to Promote Vaccine Acceptance (National Foundation for Infectious Diseases)
Thu., Apr .29, 12 PM 
REGISTER HERE
A panel discussion with experts sharing practical strategies and real-world insights to reach key audiences, including communities of color, employees, and college students.
 
Improving the Resilience of U.S. Health Care Systems for Future Pandemics (The Capitol Hill Steering Committee on Pandemic Preparedness & Health Security)
Wed., Apr. 28, 11 AM
REGISTER HERE
How can the federal government assist in tackling the problems experienced by these institutions during the COVID-19 pandemic to help them prepare for future pandemics and other health emergencies?

 
Trade Press, Journal Articles, and White Papers
Preliminary Findings of MRNA Covid-19 Vaccine Safety in Pregnant Persons. Shimabukuro, TomT., et al. “New England Journal of Medicine, 2021, doi:10.1056/nejmoa2104983
News Highlights
Federal Policy Updates
House Energy and Commerce Committee Announces Health Hearing on the Lingering Effects of COVID-19
The Health Subcommittee will hold a hearing on Wednesday, April 28, at 11 a.m. ET entitled, “The Long Haul: Forging a Path through the Lingering Effects of COVID-19.” Watch the hearing here.
SHEA Education and Events
New this week:
  1. Podcast: COVID-29 Impact on Antimicrobial Resistance (Launched 4/8)
    Note: The podcast will resume 4/29
  2. Town Hall:
    Round 46 | Sunday, April 25, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | March 19, 2021
Important Highlights
Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections During the Early Months of 2020, National Healthcare Safety Network (ICHE)
Patel, P., Weiner-Lastinger, L., Dudeck, M., Fike, L., Kuhar, D., Edwards, J., Pollock, D., Benin, A. 1-8. doi:10.1017/ice.2021.108 (2021).
Technical Guidance, Standards and Resources
Variants
Vaccines
  • 38 total questions, including new questions on variants, allergies, and fertility 
  • Animated videos explaining common side effects and the speed of development of COVID-19 vaccines
  • An interactive state map providing state public health department website information on vaccine availability and distribution 
  • Updated sharing toolkit with ready-made posts, branded solely with COVID Vaccine Facts logos
  • New partnering page displaying partner organization information and upcoming events.
 
Vaccine Monitoring
MMWRs
Infection Prevention and Control
Special Settings and Populations 
Clinical Care
Revised Monoclonal Antibody Fact Sheets re: SARS-CoV-2 Variants (FDA)
Testing and Cases
 
Communication Resources
Payment and Reimbursement Policy
Research
Information for Patients, Visitors, and the General Public
Event Announcements
American Hospital Association (AHA) Living Learning Network (LLN) Open House: Optimizing Equitable Access to COVID-19 Vaccines
Thurs., Mar. 25, 1:00-2:00 PM EDT
REGISTER 
During this one-hour event, hospitals and health systems will hear from and communicate with UCLA Health on successful strategies, creative solutions, and lessons learned around optimizing equitable access to COVID-19 vaccines.
News Highlights
Federal Policy Updates
Hearing: Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations (House Energy & Commerce Subcommittee on Oversight and Investigation)
SHEA Education and Events
New this week:
  1. Podcast: Long-Term Care Post-Vaccination
  2. Town Hall Round 44 
    Sunday, March 28, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | March 12, 2021
Important Highlights
Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination 
CDC has updated select healthcare infection prevention and control recommendations in response to COVID-19 vaccination, which are summarized in this guidance. The update covers: 
  • Visitation 
  • Work restriction for asymptomatic healthcare personnel and quarantine for asymptomatic patients and residents – including guidance for fully vaccinated HCP, inpatients, residents; quarantine and travel recommendations.
Recommendations for SARS-CoV-2 Testing and use of personal protective equipment remain unchanged. Updated recommendations will be added to this page regularly as new information becomes available. 
 
New recommendations for safe visitation in long-term care facilities 
CMS in coordination with CDC published key updates for long-term care visitation policies including: 
  • Outdoor Visitation – CMS continues to encourage all visits be held outdoors whenever practicable because of the lower risk of transmission due to increased space and airflow. 
  • Indoor Visitation – The agency now says indoor visits should always be permitted for residents, regardless of whether the resident or visitor has received a vaccine. However, CMS details three scenarios under which indoor visitation should be limited, including for: (1) Vaccinated residents, if the nursing home’s COVID-19 county positivity rate is more than 10 percent and fewer than 70 percent of residents in the facility are fully vaccinated; (2) Vaccinated or unvaccinated residents with confirmed COVID-19 infection until they meet criteria to discontinue Transmission-Based Precautions; and (3) Vaccinated or unvaccinated residents in quarantine, until they meet criteria for release from quarantine.
Importantly, the agency also notes that residents who are fully vaccinated may choose to have close, physical contact with visitors, as long as both parties are masked and hands are washed before and after contact. 
  • Indoor Visitation During an Outbreak – CMS explains that nursing homes should start outbreak testing and immediately cease all visitation after a new case of COVID-19 is identified until at least one round of facility-wide testing has occurred. The agency says that visitation can start again in other units of the facility if outbreak testing indicates there are no additional COVID-19 cases in those areas. However, if outbreak testing detects one or more COVID-19 cases in other units of the facility, the facility must stop visitation for both vaccinated and unvaccinated residents until it can meet criteria to end outbreak testing.  
  • Visitor Testing and Vaccination – The agency does not require the testing of visitors, but continues to encourage facilities in medium or high-positivity counties to test visitors, if possible. CMS notes that facilities may also encourage visitors to be tested prior to visiting and provide proof of a negative test. Similarly, the agency suggests facilities encourage visitors to get vaccinated but not require vaccination.  
  • Compassionate Care Visits – The agency explains that compassionate care visits are required under federal disability rights law and should be allowed at all times for both vaccinated and unvaccinated residents, even during an outbreak.
  • Survey Considerations – CMS notes that federal and state surveyors are not required to be vaccinated and must be allowed to enter facilities unless they display signs or symptoms of COVID-19 infection.  
Beyond the considerations detailed above, CMS continues to advise that all visitors adhere to the core principles of COVID-19 infection prevention, which include practices such as symptom screening, hand washing, wearing a mask, social distancing, instructional signage, and routine cleaning.
SHEA Coronavirus News
 
SHEA Converse & Convene: COVID-19 Variants and its Impact on Testing and Prevention Measures (Open to SHEA Members)   
REGISTER HERE
This members-only networking event will focus on questions related to the variants and the impact it has on testing and prevention measures. Please note this event is not recorded and is intended for members to have an open, candid discussion around this topic.   
Moderator: Bhagyashri Navalkele, MD, FACP, University of Mississippi Medical Center 
Technical Guidance, Standards and Resources
Vaccines 
 
MMWRs 
 
Infection Prevention and Control 
 
Testing and Cases 
 
PPE  
 
Incident Management 
 
Payment and Reimbursement Policy 
 
 
Research 
Trade Press, Journal Articles and White Papers
CDC Interim Recommendations for Fully Vaccinated People: An Important First Step. Christie A, Mbaeyi SA, Walensky RP. JAMA. Published online March 10, 2021. doi:10.1001/jama.2021.4367  
News Highlights
‘Falling through cracks’: Vaccine bypasses some older adults (Associated Press)  
  
Biden team plots the country’s first national Covid testing strategy (Politico)  
Featured Social Media
Federal Policy Updates
American Rescue Plan COVID-19 Relief Bill is Signed Into Law 
President Joe Biden signed the American Rescue Plan for COVID-19 relief into law March 11. Key provisions of interest to SHEA include: 
  • Funding for COVID-19 Vaccine Activities at CDC (Sec. 2301) – Provides $7.5 billion (available until expended) for activities to plan, prepare for, promote, distribute, administer, monitor, and track COVID-19 vaccines, including the expansion of staffing support, community vaccination centers, mobile vaccination units, and information technology, data, and reporting enhancements.  
  • Funding for Vaccine Confidence Activities (Sec. 2302) – Provides $1 billion to CDC (available until expended) to improve vaccine confidence and vaccination rates through activities that include providing further information and education.  
  • Funding for COVID-19 Vaccines and Therapeutics Supply Chain (Sec. 2303) – Provides $6.05 billion (available until expended), an increase of $850 million compared to the House-approved bill, to support research, development, manufacturing, production, and the purchase of vaccines, therapeutics, and ancillary medical products and supplies to prevent, prepare, or respond to COVID-19 and any variant.  
  • Funding for COVID-10 Vaccine, Therapeutics, and Device Activities at the FDA (Sec. 2304) – Provides $500 million (available until expended) for activities related to the emerging COVID-19 variants and evaluating the performance of existing authorized therapeutics, vaccines, and diagnostics, as well as the oversight of the supply chain and mitigation of shortages.  
  • Funding for COVID-19 Testing, Contact Tracing, and Mitigation Activities (Sec. 2401) – Provides $47.8 billion, an increase of $1.8 billion compared to the House-approved bill, (available until expended) for activities to detect, diagnose, trace, and monitor COVID-19. These activities include: (1) the implementation of a national testing and contact tracing strategy; (2) technical assistance, guidance, and grants to state, local, and territorial public health departments for testing and contact tracing; and (3) enhancing information technology and data modernization.  
  • Funding for SARS-COV-2 Genomic Sequencing and Surveillance (Sec. 2402) – Provides $1.75 billion (available until expended) to strengthen and expand activities and workforce related to the genomic sequencing and disease surveillance of new COVID-19 strains, as well as grants to state, local, and territorial health departments to support their capacity in identifying and sequencing new strains.  
  • Funding for Global Health (Sec. 2403) – Provides $750 million to the CDC (available until expended) to combat COVID-19 and other emerging infectious diseases worldwide, including activities related to global health security, global disease detection and response, global immunization, and global coordination on public health.  
  • Funding for Data Modernization and Forecasting Center (Sec. 2404) – Provides $500 million to the CDC (available until expended) for the purposes of public health data surveillance and analytics infrastructure modernization initiatives. The CDC is also to establish, expand, and maintain efforts to modernize the U.S. disease warning system to forecast and track hotspots for COVID-19, its variants, and other emerging threats.  
  • Funding for Public Health Workforce (Sec. 2501) – Provides $7.66 billion (available until expended) for efforts to establish, expand, and sustain a public health workforce through making awards to state, local, and territorial public health departments. Positions include investigators, contact tracers, social support specialist, community health workers, public health nurses, disease intervention specialist, and epidemiologist, among other professionals. The funding also supports personal protective equipment (PPE), data management, and administrative costs.  
  • Funding for Infection Control Support to Skilled Nursing Facilities (Sec. 9401) – Provides $200 million (available until expended) to HHS to support infection control activities at skilled nursing facilities through contracts with quality improvement organizations.  
  • Funding for Strike Teams in Skilled Nursing Facilities (Sec. 9402) – Provides $250 million to HHS (available until expended) for the purposes of allocating funding to States (including the District of Columbia and each territory) to support the creation and implementation of strike teams to respond to COVID-19 outbreaks in skilled nursing facilities.  
  • Funding for State Strike Teams for Nursing Home Safety (Sec. 9818) – Provides $250 million (available until expended) to the U.S. Department of Health and Human Services (HHS) for allocating funding to states to establish and implement COVID-19 strike teams for deployment to nursing facilities that include diagnosed or suspected cases of COVID-19. Strike teams will provide assistance with clinical care, infection control, or staffing.
Hearing: Examining Our COVID-19 Response: An Update from the Frontlines (Senate HELP Committee)  
 
Murray Re-Introduces Public Health Infrastructure Save Lives Act As New Report Looks At Gaps In Preparedness (Senate HELP Committee) 
 
Senator Patty Murray (D-WA), Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee re-introduced on March 10 the Public Health Infrastructure Saves Lives Act (PHISLA). PHISLA would establish a core public health infrastructure program to strengthen the country’s public health system—including the nation’s ability to respond to the COVID-19 pandemic—through grants to State, territorial, local, and Tribal health departments and increased investments at the Centers for Disease Control and Prevention (CDC). The bill also supports development and implementation of national public health accreditation. The funding for the program would ramp up over five years to $4.5 billion annually and then remain at that level, and the program would be aimed at specifically addressing eight core capabilities: 
  1. Public health assessment  
  2. Preparedness and response 
  3. Policy development and support 
  4. Communications 
  5. Community partnership development 
  6. Organizational competencies 
  7. Accountability 
  8. Equity
In a letter led by Trust for America’s Health (TFAH), SHEA endorsed the bill. Read the fact sheet here
SHEA Education and Events
New this week:
  1. Podcast: South Africa Perspective on COVID & Variants
  2. Town Hall Round 43 (Long-Term Care focus) 
    Special COVID-19 Israeli perspective presentation by Dr. Mitchell Schwaber
    Sunday, March 14, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203

banner002.jpg
COVID-19 Update | March 5, 2021
SHEA Coronavirus News
SHEA Converse & Convene: COVID-19 Variants and its Impact on Testing and Prevention Measures (Open to SHEA Members)   
REGISTER HERE
This members-only networking event will focus on questions related to the variants and the impact it has on testing and prevention measures. Please note this event is not recorded and is intended for members to have an open, candid discussion around this topic.   
Moderator: Bhagyashri Navalkele, MD, FACP, University of Mississippi Medical Center 
Technical Guidance, Standards and Resources
Vaccines 
 
MMWRs 
Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program — Israel, December 2020–February 2021 (CDC MMWR)  
 
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 (CDC MMWR)  
 
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020 (CDC MMWR)  
 
SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital — New York City, April 2020 (CDC MMWR)  
 
Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant — Texas, January 2021 (CDC)  
 
First Identified Cases of SARS-CoV-2 Variant P.1 in the United States — Minnesota, January 2021 (CDC MMWR)  
 
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 (CDC MMWR)  
 
Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, on Signing the Advisory Committee on Immunization Practices’ Recommendation to Use Janssen’s COVID-19 Vaccine in People 18 and Older (CDC ACIP)  
 
Special Settings and Populations 
 
Clinical Care 
 
Testing and Cases 
 
Occupational Health 
Event Announcements
The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events (CDC COCA) 
Thurs. Mar. 11, 2PM-3PM ET 
Presenters: Erica Tindall, MSN, MPH, APRN, AGNP-C, CIC, Ann Mond Johnson, Mandy Reed, Michelle Rizor, MHSA, Daniel Smith, PA-C, Todd Vento, MD, MPH, FACP, FIDSA  
 
CDC COVID-19 Partner Update: Expanding the COVID-19 Vaccination Toolbox: An Update on Johnson & Johnson’s Janssen Vaccine EUA and New Federal Vaccination Programs (CDC COCA) 
Monday, Mar. 8, 3PM ET
REGISTER 
Presenter: Dr. Cynthia Ogden 
Trade Press, Journal Articles and White Papers
Persistent SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19The Journal of Infectious Diseases, 2021; jiab107, https://doi.org/10.1093/infdis/jiab107 Daniel Owusu, et al. 
 
Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March – August, 2020Clinical Infectious Diseases, 2021; ciab185, https://doi.org/10.1093/cid/ciab185 Travis Lim, DrPH, et al. 
Federal Policy Updates
OSHA Exploring and Emergency Temporary Standard for Protection from Infectious Diseases 
Background. The updated Heroes Act, passed by the House last October, included a provision that would require OSHA to issue an emergency temporary standard (ETS) within 7 days of enactment and a permanent infectious disease standard within 24 months of enactment. See Sec. 202 on p. 23 of the section-by-section
 
The ETS would: 
  • Require employers to conduct a hazard assessment and develop and implement a comprehensive infectious disease exposure control plan to protect workers from COVID-19; 
  • Require employers to implement appropriate controls, provide worker training and report outbreaks to OSHA and public health authorities; and  
  • Incorporates, as appropriate, guidance issued by the CDC, NIOSH, and OSHA  
Based on the proposed statutory requirements for the ETS, we could expect a similarly high-level ETS from OSHA by March 15 (if the agency decides an ETS is necessary). A permanent infectious disease standard would likely be more prescriptive and entail a public comment period at a later time. An Executive Order (EO) signed by President Biden on January 21 calls for OSHA to issue an ETS by March 15 or provide a report on why the agency would not move forward with one.  
 
A Department of Labor OIG report includes a recommendation for an ETS. Labor OIG states: “Having an ETS could be of importance during the pandemic as enforceable criteria because under the OSH Act’s General Duty Clause, violations are rarely issued.”  Recommendations are on p. 16 of the report and OSHA’s written response is on p. 29.  
 
OIG Recommendation 4: Analyze and determine whether establishing and infectious disease-specific Emergency Temporary Standard (ETS) is necessary to help control the spread of COVID-19 as employees return to worksites. 
 
OSHA Response: OSHA accepts the recommendation. Pursuant to President Biden’s January 21, 2021, Executive Order on Protecting Worker Health and Safety, the agency is already considering whether any emergency temporary standards on COVID-19, including with respect to masks in the workplace, are necessary.
  
 
The House Energy and Commerce Committee issued a press statement urging CDC and OSHA to take steps to address aerosol transmission of COVID-19. Members of the committee sent a letter to senior administrative officials and cited a similar letter from a group of subject matter experts, among them Dr. Michael Olsterholm of CIDRAP.  
 
Final Stretch: American Rescue Plan Act of 2021 
The Senate is expected to pass the American Rescue Plan Act of 2021 along party lines after debate and a vote likely to take place over the weekend. The House has adjourned for the week and will take up the package next week. Congress is on track to pass and send the revised COVID-19 relief package to President Joe Biden for his signature ahead of the March 14 expiration of federal unemployment benefits.  
 
With respect to the health-related provisions, the Senate maintains most of the legislative language approved by the House in their substitute amendment. The changes consist of revisions to funding levels, reallocation of funding to specified programs, and the exclusion of certain provisions approved by the House. Notably, the Senate amendment does not replenish the Provider Relief Fund. Some of the key provisions include: 
  • Coronavirus Relief Fund (Sec. 9901) – The Senate maintains House-approved levels of funding to states ($195.3 billion), territories ($4.5 billion), and Tribal governments ($20 billion) but reduces the House-approved levels of direct funding to localities ($120.2 billion) to provide $10 billion for the new Coronavirus Capital Projects Fund. The Senate also establishes new guardrails regarding the distribution and use of funds.  
  • Funding for COVID-19 Testing, Contact Tracing, and Mitigation Activities (Sec. 2401) – The Senate provides $47.8 billion, an increase of $1.8 billion compared to the House-approved bill, (available until expended) for activities to detect, diagnose, trace, and monitor COVID-19.  
SHEA Education and Events
New this week:
  1. Podcast: UK Perspective on Variants with Dr. Sharon Peacock, Director of the COVID-19 Genomics UK Consortium
  2. Town Hall Round 43 (Long-Term Care focus) 
    Special COVID-19 Israeli perspective presentation by Dr. Mitchell Schwaber
    Sunday, March 14, 2021 | 3:00 pm ET 
    REGISTER HERE or watch live on Facebook
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203